Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Switzerland: a life sciences hub

Switzerland: a life sciences hub The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.

AI: the smart money is on the smart thinking

AI: the smart money is on the smart thinking Bayer and Merck &Co provide a perfect example of this. They have developed an AI software system to support clinical decision-making of chronic thromboembolic pulmonary hypertension (CTEPH) – a rare form ... Bayer and Merck &Co hope that radiologists

Merck, Bayer get FDA priority review for heart failure drug

Merck, Bayer get FDA priority review for heart failure drug Despite the mixed results, Merck and Bayer decided to take their chances and advanced the vericiguat clinical programme into phase 3. ... clinicians. With the FDA priority review in their pocket, Merck and Bayer can expect a decision by 20 January 2021.

New data reinforces safety profile of Roche’s Hemlibra

New data reinforces safety profile of Roche’s Hemlibra s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla.

The best work in healthcare communications shines at virtual Communiqué Awards

The best work in healthcare communications shines at virtual Communiqué Awards 13. Excellence in Social Media Strategy. Sponsored by Evoke KYNE. Winner: Tackle TD: On the Sidelines by Havas SO for Bayer.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics